Reported Standalone quarterly numbers for Kwality Pharmaceuticals are:Net Sales at Rs 68.80 crore in March 2023 up 7.44% from Rs. 64.04 crore in March 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 7.36 crore in March 2023 down 172.46% from Rs. 10.15 crore in March 2022.
EBITDA stands at Rs. 12.98 crore in March 2023 down 27.2% from Rs. 17.83 crore in March 2022.
Kwality Pharmac shares closed at 260.45 on May 26, 2023 (BSE) and has given -21.79% returns over the last 6 months and -37.56% over the last 12 months.
| Kwality Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 68.80 | 56.01 | 64.04 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 68.80 | 56.01 | 64.04 | | EXPENDITURE | | Consumption of Raw Materials | 30.58 | 23.89 | 28.07 | | Purchase of Traded Goods | 0.02 | -- | 0.50 | | Increase/Decrease in Stocks | 4.08 | -3.30 | 3.72 | | Power & Fuel | -- | -- | -- | | Employees Cost | 7.87 | 8.03 | 5.84 | | Depreciation | 4.42 | 3.54 | 2.75 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 14.74 | 12.22 | 9.69 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 7.10 | 11.63 | 13.48 | | Other Income | 1.46 | 0.35 | 1.60 | | P/L Before Int., Excpt. Items & Tax | 8.56 | 11.98 | 15.08 | | Interest | 1.67 | 1.95 | 1.03 | | P/L Before Exceptional Items & Tax | 6.89 | 10.03 | 14.06 | | Exceptional Items | -16.53 | -- | -- | | P/L Before Tax | -9.64 | 10.03 | 14.06 | | Tax | -2.28 | 2.80 | 3.90 | | P/L After Tax from Ordinary Activities | -7.36 | 7.23 | 10.15 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -7.36 | 7.23 | 10.15 | | Equity Share Capital | 10.38 | 10.38 | 10.38 | | Reserves Excluding Revaluation Reserves | -- | -- | 171.38 | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -7.15 | 6.92 | 9.78 | | Diluted EPS | -7.15 | 6.92 | -- | | EPS After Extra Ordinary | | Basic EPS | -7.15 | 6.92 | 9.78 | | Diluted EPS | -7.15 | 6.92 | -- | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
